ImmixBio Announces Dr. Galit Lahav of Harvard Medical School Joins Scientific Advisory Board

LOS ANGELES: LOS ANGELES, Aug. 17, 2021 /PRNewswire/ -- Immix Biopharma, Inc. ("ImmixBio"), a biotechnology company pioneering Tissue Specific Therapeutics (TSTx)™ for oncology and inflammation, today announced that Galit Lahav, PhD, Novartis Professor of Systems Biology and Department Chair, Systems Biology at Harvard Medical School has joined its Scientific Advisory...

Click to view original post